ELUCIDATION OF THE INTRACELLULAR CALCIUM SIGNAL TRANSDUCTION WITH THE MOLECULAR PHARMACOLOGICAL APPROARCH
ELUCIDATION OF THE INTRACELLULAR CALCIUM SIGNAL TRANSDUCTION WITH THE MOLECULAR PHARMACOLOGICAL APPROARCH
批准号:
06404019
负责人:
HIDAKA Hiroyoshi
金额:
$22.21万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A)
财政年份:
1994
资助国家:
日本
项目状态:
已结题
起止时间:
1994 至 1996
中文摘要
细胞信号的研究在过去的10年里取得了突破性的进展,它依赖于生理、生化和酶的研究,并引入了分子生物学的方法,如克隆基因。我们从蛋白质化学、分子生物学和分子药理学的角度研究了细胞内钙信号转导系统的分子基础。我们研究了一种新的钙/钙调蛋白依赖的蛋白激酶V(CaM Kinase V)被磷酸化激活的机制。在此基础上,制备了抗CaM激酶V的多克隆抗体,并对其组织分布和免疫组织化学定位进行了研究。然后我们发现了CaM激酶V-激活剂,它是CaM激酶V催化活性所必需的。有趣的是,CaM激酶V激活剂确实使与其激活相关的钙/钙调蛋白依赖的蛋白激酶IV(CaM激酶IV)磷酸化。最后,我们推测可能存在新的CaM激酶级联,如MAP激酶级联。我们一直在研究利用合成的分子来激活或抑制靶分子的活性来分析生物功能。在这些研究的基础上,我们设计了作用于细胞内信号转导的分子探针,阐明了与细胞内信号转导密切相关的CaM激酶的生理功能。最近,我们从大鼠脑中克隆了两个新的钙/钙调蛋白依赖性蛋白激酶I(CaM Kinase I)亚型,而CaM Kinase V被认为是CaM Kinase I的一个亚型。
英文摘要
Research on cellular signals, which depend heavily on physiological, biochemical and enzymatic studies, has made a rapid progress in the last 10 years with the break through introduction of such molecular biotogical approach as cDNA cloning. We studied molecular basis of the intracellular calcium signal transduction system by protein chemical, molecular biological, and molecular pharmacological approach. We have examined the mechanisms by which a novel Ca2+/calmodulin-dependent protein kinase V(CaM kinase V) was activated by phosphorylation. Physicochemical or biochemical properties of CaM kinase V were also analyzed Furthermore, polyclonal antibody against CaM kinase V was prepared and tissue distribution and immunohistochemical localization of CaM kinase V were studied. We have then discovered the CaM kinase V-activator which was necessary for CaM kinase V catalytic activity. Interestingly, the CaM kinase V-activator did phosphorylate Ca2+/calmodulin-dependent protein kinase IV(CaM kinase IV)associated with its activation. Finally, we suggested that there were new CaM kinase cascades such as those of MAP kinase. We have been studying to analyze biological function using synthesized molecule to activate or inhibit the activities of the target molecule. Based on these studies in creating designed molecular probes acting in the intracellular signal transduction, we have clarified the physiological functions of the CaM kinase which are closely linked to the intracellular signal transduction. Recently, we have cloned two new Ca2+/calmodulin-dependent protein kinase I(CaM kinase I) isoforms from rat brain and CaM kinase V has been thought to be an isoform of CaM kinase I.
期刊论文(71)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
S.Satoh: "Neuroprotecive properties of a protein kinase inhibitor against ischacmia-induced neuronal damage in rats and gerbils." Br. J. Pharmacol.118. 1592-1596 (1996)
S.Satoh:“蛋白激酶抑制剂对大鼠和沙鼠缺血引起的神经元损伤的神经保护特性。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
N.H.Obata: "Effect of KN-62, Ca^<2+>/calmodulin-dependent protein kinase II inhibitor, on adriamycin-resistance of human ovarian cancer cells." Biochem. Biophys. Res. Commun.215・2. 566-571 (1995)
N.H.Obata:“KN-62、Ca^2+/钙调素依赖性蛋白激酶 II 抑制剂对人类卵巢癌细胞的阿霉素耐药性的影响”,Biochem.215·2。 571 (1995)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
H.Minami: "The effect of KN-62, Ca^<2+>/calmodulin-dependent protein kinase II inhibitor on cell cycle." Biochem. Biophys. Res. Commun.199・1. 241-248 (1994)
H.Minami:“KN-62、Ca^2+/钙调蛋白激酶 II 抑制剂对细胞周期的影响。Biochem.199·1”。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
K.Okazaki: "KN-62, a specific Ca^<2+>/calmodulin-dependent protein kinase inhibitor, reversibly depresses the rate of beating of cultured fetal mouse cardiac myocytes" J. Pharmacol. Exp. Ther.270・3. 1319-1324 (1994)
K.Okazaki:“KN-62,一种特定的Ca^2+/钙调蛋白依赖性蛋白激酶抑制剂,可逆地抑制培养的胎儿小鼠心肌细胞的跳动率”J.Pharmacol Exp.270・3。 1319-1324 (1994)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
D.Findik: "Protein kinase A inhibitors enhance radiation-induced apoptosis." J.Cell.Biochem.57. 12-21 (1995)
D.Findik:“蛋白激酶 A 抑制剂可增强辐射诱导的细胞凋亡。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 43 条
Molecular basis and generation of new compounds for probing phosphorylation-mediated signaling pathways
-
批准号:06507001
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$19.14万
-
财政年份:1994
-
负责人:HIDAKA Hiroyoshi
-
依托单位:
Nuclear magnetic resonance studies of calcyclin and annexin XI.
-
批准号:06044105
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$7.04万
-
财政年份:1994
-
负责人:HIDAKA Hiroyoshi
-
依托单位:
Establishment of the pharmacological sciences to elucidate the signal transduction system.
-
批准号:04304030
-
项目类别:Grant-in-Aid for Co-operative Research (A)
-
资助金额:$9.6万
-
财政年份:1992
-
负责人:HIDAKA Hiroyoshi
-
依托单位:
The Development of the Strategy for the Presumption of the Tertiary Structure of Protein Kinases by Specific Inhibitors
-
批准号:02557009
-
项目类别:Grant-in-Aid for Developmental Scientific Research (B)
-
资助金额:$7.42万
-
财政年份:1990
-
负责人:HIDAKA Hiroyoshi
-
依托单位:
Unification and reconstruction of myosin phosphorylation theory on contractile response of smooth muscle and nonmuscle cells.
-
批准号:01044066
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$4.67万
-
财政年份:1989
-
负责人:HIDAKA Hiroyoshi
-
依托单位:
The role of Ca^<2+>-dependent protein kinases in central nervous system in health and diseases.
-
批准号:01440027
-
项目类别:Grant-in-Aid for General Scientific Research (A)
-
资助金额:$12.35万
-
财政年份:1989
-
负责人:HIDAKA Hiroyoshi
-
依托单位:
Development of analytical method of molecular function in protein kinases by using newly synthesized protein kinase inhibitor - affinity chromatography
-
批准号:62880018
-
项目类别:Grant-in-Aid for Developmental Scientific Research
-
资助金额:$4.03万
-
财政年份:1987
-
负责人:HIDAKA Hiroyoshi
-
依托单位:
Molecular pharmacological approarches of intracellular calcium regulatory mechanisms
-
批准号:62480119
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$3.84万
-
财政年份:1987
-
负责人:HIDAKA Hiroyoshi
-
依托单位:
Study on new types of calcium antagonists
-
批准号:58870019
-
项目类别:Grant-in-Aid for Developmental Scientific Research
-
资助金额:$3.97万
-
财政年份:1983
-
负责人:HIDAKA Hiroyoshi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
好忘方通过STIM1-Ca2+/Calmodulin-eEF2信号通路治疗阿尔茨海默病的机制研究
-
批准号:82104416
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:刘妍
-
依托单位:
凡纳滨对虾Ca2+/Calmodulin信号通路在低盐逆境条件下的应答调节作用研究
-
批准号:31602135
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2016
-
负责人:黄文
-
依托单位:
VEGF下调Calmodulin维持肝窦内皮细胞窗孔结构在肝纤维化中的作用及机制
-
批准号:81600485
-
项目类别:青年科学基金项目
-
资助金额:17.0万元
-
批准年份:2016
-
负责人:程恒辉
-
依托单位:
Calmodulin的N环和C环与心肌CaV1.2钙通道的多个结合位点交互作用介导其Ca2+依赖性失活的机制研究
-
批准号:31471091
-
项目类别:面上项目
-
资助金额:86.0万元
-
批准年份:2014
-
负责人:郝丽英
-
依托单位:
Ca2+/Calmodulin通路与炎性肌损伤免疫反应的相关性研究
-
批准号:81371924
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2013
-
负责人:廖华
-
依托单位:
虎杖苷通过靶向抑制Ca2+/calmodulin激活的calcineurin-NFAT信号通路治疗心肌肥大的研究
-
批准号:81200122
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2012
-
负责人:邓建新
-
依托单位:
Ca2+/Calmodulin/NFATc1信号通路在双膦酸盐诱发破骨细胞生成抑制中作用及机制研究
-
批准号:81270965
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2012
-
负责人:戚孟春
-
依托单位:
出血性血小板病ADAM17和Calmodulin介导的血小板GPⅠb-Ⅸ-Ⅴ亚基水解活性研究及益气活血方的干预效应
-
批准号:81072945
-
项目类别:面上项目
-
资助金额:34.0万元
-
批准年份:2010
-
负责人:沈霖
-
依托单位:
L型钙通道调节机制中calpastatin 和calmodulin的相互作用
-
批准号:30670761
-
项目类别:面上项目
-
资助金额:26.0万元
-
批准年份:2006
-
负责人:郝丽英
-
依托单位: